The carbohydrate moieties on glycoproteins, including immunoglobulins
(Ig), are involved in a broad spectrum of biological functions. As rev
ealed by enzymatic or chemical removal of carbohydrate moieties, inhib
ition of glycosylation, or site-directed mutagenesis of asparagine res
idues to prevent N-linked glycosylation, carbohydrates on Ig have been
shown to participate in binding, internalization and catabolism by he
patocytes or other cells, binding to Fc receptors on phagocytic cells,
activation of complement, and opsonization. The structure of human Ig
A1 is unique among all Ig. The heavy chain contains a hinge region wit
h a characteristic primary structure not seen in any other Ig. and whi
ch contains five short O-linked oligosaccharide side-chains composed o
f serine-linked N-acetylgalactosamine (GalNAc) and beta 1-3-linked gal
actose (Gal). Both of these monosaccharides may be sialylated. In cont
rast to ubiquitous N-linked sidechains, O-linked carbohydrate moieties
are found rarely among human serum glycoproteins. We have demonstrate
d that IgA1 proteins from the sera of patients with IgA nephropathy (I
gAN) are galactosylated to a lesser extent than those from healthy con
trols. Decreased content of Gal and decreased reactivity of IgA from I
gAN patients with lectins specific for GalNAc indicate that these stru
ctural changes occur on glycans located in the hinge region of IgA1. T
hus, in addition to rheumatoid arthritis, systemic lupus erythmatosus,
inflammatory bowel disease and other disorders, IgA nephropathy may re
present another example of a chronic disease in which aberrancies of c
arbohydrates are observed and may participate in aetiopathogenesis.